Estrogen and progesterone receptors in murine models of systemic lupus erythematosus

International Immunopharmacology

Volumn 1, Issue 6, 2001, Pages 1025-1035

  Greenstein, Ben ^a   Roa, Ryan ^a   Dhaher, Yacoub ^b   Nunn, Elizabeth ^c   Greenstein, Adam ^d   Khamashta, Munther ^e   Hughes, Graham R V ^e  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Medicare ^*  (Israel)

^c Schiller International University   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; Estrogen receptors; Mouse; Progesterone receptors; Systemic lupus erythematosus

Indexed keywords

CELL RECEPTOR; ESTRADIOL; ESTRADIOL RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; DISEASE COURSE; HORMONE ACTION; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0035034215     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00034-0     Document Type: Review

References (70)

1. Ahmed S., Penhale W.J., Talal N. Sex hormones, immune response and autoimmune disease: mechanism of sex hormone action. Am. J. Pathol. 121:1985;531-551.
2. Hayslett J.P., Reece E.A. Systemic lupus erythematosus in pregnancy. Clin. Perinatol. 12:1985;539-550.
3. Beaumont V., Gioud-Paquet M., Kahn M.F., Beaumont J.L. Antiestrogen antibodies, oral contraception and systemic lupus erythematosus. Clin. Physiol. Biochem. 7:1989;263-289.
4. Lahita R.G., Bradlow H.L. Hormone metabolism in patients with Klinefelter's disease and SLE. J. Rheumatol. 14:1987;154-157.
5. Lahita R.G., Bradlow H.L., Fishman J., Kunkel H.G. Abnormal estrogen and androgen metabolism in the human with systemic lupus erythematosus. Am. J. Kidney Dis. 2:1982;206-211.
6. Lahita R.G., Bradlow H.L., Kunkel H.G., Fishman J. Increased 16-alphahydroxylation of estradiol in systemic lupus erythematosus. Clin. Endocrinol. Metab. 53:1981;174-178.
7. Theofilopoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:1985;269-390.
8. Andrews B.S., Eisenberg R.A., Theofilopoulos A.N., Izui S., Wilson C.B., McConahey P.J.et al. Spontaneous murine lupus-like syndromes: clinical and immunological manifestations in several strains. J. Exp. Med. 148:1978;1198-1215.
9. Nadeau J.H., Davisson M.T., Doolittle D.P., Grant P., Hillyard A.L., Kosowsky M.et al. Comparative map for mice and humans. Mamm. Genome. 1:1991;S461-S515.
10. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314-317.
11. Wu J., Zhou T., He J., Mountz J.D. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:1993;461-468.
12. Lambert P.H., Dixon F.J. Pathogenesis of the glomerulonephritis of NZB/W mice. J. Exp. Med. 127:1968;507-522.
13. Papoian R., Pillarisetty R., Talal N. Immunologic regulation of spontaneous antibodies to DNA and RNA: II. Sequential switch from IgM to IgG in NZB/NZWF1 mice. Immunology. 32:1977;75-79.
14. Izui S., McConahey P.J., Theofilopoulos A.N., Dixon F.J. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J. Exp. Med. 149:1979;1099-1116.
15. Izui S., Elder J.H., McConahey P.J., Dixon F.J. Identification of retroviral gp70 and anti-gp70 antibodies involved in circulating immune complexes in NZB×NZW mice. J. Exp. Med. 153:1981;1151-1160.
16. Maruyama N., Furukawa F., Nakai Y., Sasaki Y., Ohta K., Ozaki S.et al. Genetic studies of autoimmunity in New Zealand mice: IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB×NZW)F1 hybrid and the correlation to renal disease. J. Immunol. 130:1983;740-746.
17. Verheul H.A., Verveld M., Hoefakker S., Schuurs A.H. Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunopharmacol. Immunotoxicol. 17:1995;163-180.
18. Roubinian J.R., Talal N., Greenspan J.S., Goodman J.R., Siiteri P.K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 147:1978;1568-1583.
19. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K.et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
20. Couse J.F., Lindzey J., Grandien K., Gustafsson J.-A., Korach K.S. Tissue distribution and quantitation analysis of estrogen receptor-α (ER-α) and estrogen receptor-β (ER-β) messenger ribonucleic acid in the wild-type and ER-α knock-out mouse. Endocrinology. 138:1997;4613-4621.
21. Athreya B.H., Moore W.C., Wadsworth S.A., Gupta C., Goldman A.S. Estrogen receptor levels in a murine model of systemic lupus erythematosus. Clin. Exp. Rheumatol. 7:1989;589-593.
22. Roa R., Greenstein B.D. Evidence for estrogen receptor pleomorphism of receptor capacity and affinity in liver and thymus of immature BALB/c and (NZB×NZW)F1 mice, a model of systemic lupus erythematosus. Intl. J. Immunopharmacol. 22:2000;897-903.
23. Thomas T., Gunnia U.B., Seibold J.R., Thomas T.J. Restoration of the DNA binding activity of estrogen receptor in MRL-lpr/lpr mice by a polyamine biosynthesis inhibitor. Arthritis Rheuma. 34:1991;55-62.
24. Greenstein B.D., Dhaher Y.Y., Bridges E. de F., Keser G., Khamashta M.A., Greenstein A.S.et al. Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice. Lupus. 2:1993;221-225.
25. Dhaher Y.Y., Greenstein D., Nunn E., de Fougerolles R., Khamashta M., Hughes G.R.V. Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus. Int. J. Immunopharmacol. 22:2000;247-254.
26. Carlsten H., Nilsson N., Jonsson R., Backman K., Holmdahl R., Tarkowski A. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell. Immunol. 144:1992;190-202.
27. Apelgren L.D., Bailey D.L., Fouts R.L., Short L., Byan N., Evans G.F.et al. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell. Immunol. 173:1996;55-63.
28. Zuckerman S.H., Bryan Poole N. Estrogen-induced alterations in lipoprotein metabolism in autoimmune MRL/lpr mice. Arterioscler., Thromb., Vasc. Biol. 15:1995;1556-1562.
29. Raynaud J.P., Martin P.M., Bouton M.M., Ojasoo T. 11beta-Methoxy-17-ethynyl-1,3,5(10)-estratriene-3,17beta-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues. Cancer Res. 38:1978;3044-3050.
30. + B cells in the liver of autoimmune (NZB×NZW) F1 mice. Microbiol. Immunol. 37:1993;221-228.
31. Liai T., Kimura M., Hirokawa K., Watanabe H., Hatakeyama K., Abo T. Characterization of intermediate T-cell receptor cells expanding in the liver, thymus and other organs in autoimmune lpr mice: parallel analysis with their normal counterparts. Immunology. 84:1995;601-608.
32. Rochman H., Rosner B., Mathey B., Getz G.E., Hospelhorn V. Age, sex and gonadal influences on oestrogen receptor content in the rat liver. J. Endocrinol. 106:1985;95-102.
33. Yu M.S., Ho S.M. Nuclear acceptors for estrogen-receptor complexes in the liver of the turtle Chrysemys picta: I. Sexual differences, species specificity and hormonal dependency. Mol. Cell. Endocrinol. 61:1989;37-48.
34. Haug B.L., Sibley J.T., Lee J.S. Increased synthesis of poly (ADP-ribose) in isolated liver nuclei from autoimmune NZB/NZW mice. FEBS Lett. 215:1987;252-256.
35. - Tαβ cells in the liver is a common feature of autoimmune mice. J. Immunol. 147:1991;2907-2912.
36. Emmendorffer A., Muller M., Wedekind D., Hartung K., Lohman-Matthes M.-L. Expansion of the liver-associated macrophage system in systemic lupus erythematosus-prone NZB/W mice. J. Leukocyte Biol. 53:1993;294-300.
37. Stites D.P., Siiteri P.K. Steroids as immunosuppressants in pregnancy. Immunol. Rev. 75:1983;117-138.
38. Van Vlasselaer P., Goebels J., Vandeputte M. Inhibition of lymphocyte aggregation by progesterone. J. Reprod. Immunol. 9:1986;111-121.
39. Vinijsanun A., Martin L., Wang D.Y., Fantl V.E. Effects of a monoclonal antibody against progesterone, on embryo transport, development and implantation in laboratory mice. Reprod., Fertil. Dev. 2:1990;395-405.
40. Szekeres-Bartho J., Par G., Szewreday L., Smart C.Y., Achatz I. Progesterone and non-specific immunologic mechanisms in pregnancy. Am. J. Reprod. Immunol. 38:1997;176-182.
41. 2+ signaling, and gene expression in T-lymphocytes. J. Exp. Med. 188:1998;1593-1602.
42. Baulieu E.E. Interaction of steroid hormones with their target cells. Reprod., Nutr. Develop. 2:1980;419-441.
43. Bagchi M.K., Tsai M.J., O'Malley B.W., Tsai S.Y. Analysis of the mechanism of steroid hormone receptor-dependent gene activation in cell-free systems. Endocr. Rev. 13:1992;525-535.
44. Greenstein B.D. Evidence for specific progesterone receptors in rat brain cytosol. J. Endocrinol. 79:1978;327-338.
45. Sumida C., Gelly C., Pasqualini J.R. Progesterone and oestradiol receptors in the uterus of oestradiol-primed fetal and newborn guinea-pigs. J. Endocrinol. 85:1980;429-434.
46. Fujii-Hanamoto H., Grossman C.J., Roselle G.A., Mendenhall C.L., Seiki K. Nuclear progestin receptors in rat thymic tissue. Thymus. 15:1990;31-45.
47. MacLusky N.J., McEwen B.S. Oestrogen modulates progestin receptor activity in some brain regions but not in others. Nature. 274:1978;276-278.
48. Roselli C.E., Snipes C.A. Cytoplasmic receptors in the hypothalamus-preoptic area of the mouse: effect of estrogen priming. J. Steroid Biochem. 19:1983;1571-1575.
49. Al-Khouri H., Greenstein B.D. Progesterone receptors in rat brain and uterus: dependence on the hormonal milieu. J. Endocrinol. 107:1985;159-162.
50. Bogic L., Gerlach J.L., McEwen B.S. The ontogeny of sex differences in estrogen-induced progesterone receptors in rat brain. Endocrinology. 122:1988;2735-2741.
51. Warembourg M., Jolivet A., Milgrom E. Immunohistochemical evidence of estrogen and progesterone receptors in the same neurons of the guinea pig hypothalamus and preoptic area. Brain Res. 480:1989;1-15.
52. Thi A.D., Yung-Testas I., Baulieu E.E. Neuronal signals are required for estrogen-mediated induction of progestereone receptor in cultured rat Schwann cells. J. Steroid Biochem. Mol. Biol. 67:1998;201-211.
53. Seiki K., Imanishi Y., Haruki Y., Enomoto T. Estrogen receptor in the thymus of castrated mice. Endocrinol. Jpn. 26:1979;159-165.
54. Kawashima I., Seiki K., Sakabe K., Ihara S., Akatsuka A., Katsumata Y. Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus. Thymus. 20:1992;115-121.
55. Grossman C.J., Sholiton L.J., Nathan P. Rat thymic estrogen receptor - I. Preparation, location and physiochemical properties. J. Steroid Biochem. 11:1979;1233-1240.
56. Malacarne P., Piffanelli A., Indelli M., Fumero S., Mondino A., Gionchiglia E.et al. Estradiol binding in rat thymus cells. Horm. Res. 12:1980;224-232.
57. Screpanti I., Gulino A., Pasqualini J.R. The fetal thymus of guinea pig as an estrogen target organ. Endocrinology. 111:1982;1552-1561.
58. Ranelletti F.O., Carmignani M., Marchetti P., Natoli C., Iacobelli S. Estrogen binding by neoplastic human thymus cytosol. Eur. J. Cancer. 16:1980;951-955.
59. Danel L., Souweine G., Monier J.C., Saez S. Specific estrogen binding sites in human lymphoid cells and thymic cells. J. Steroid Biochem. 118:1983;559-563.
60. Nilsson B., Carlsson S., Damber M.G., Lindblom D., Sodergard R., von Schoultz B. Specific binding of 17 beta-estradiol in the human thymus. Am. J. Obstet. Gynecol. 149:1984;544-547.
61. Dhaher Y.Y., Chan K., Greenstein B.D., de Fougerolles Nunn E., Khamashta M.A., Hughes G.R.V. Impaired estrogen priming of progesterone receptors in uterus of MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus (SLE). Int. J. Immunopharmacol. 22:2000;537-545.
62. Levin E.R. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol. Metab. 10:1999;374-377.
63. 3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α Steroids. 64:1999;5-13.
64. Watson C.S., Gametchu B. Membrane-initiated steroid actions and the proteins that mediate them. Proc. Soc. Exp. Biol. Med. 220:1999;9-19.
65. Rider V., Foster R.T., Evans M., Suenaga R., Abdou N.I. Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin. Immnunol. 89:1998;171-180.
66. Suenaga R., Evans M.J., Mitamura K., Rider V., Abdou N.I. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J. Rheumatol. 25:1998;1305-1312.
67. Thurmond T.S., Murante F.G., Staples J.E., Silverstone J.E., Korach K.S., Gasiewicz T.A. Role of estrogen receptor α in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology. 141:2000;2309-2318.
68. Reininger L., Winkler T.H., Kalberer C.P., Jourdan M., Melchers F., Rolink A.G. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB×NZW)F1 mice. J. Exp. Med. 184:1996;853-861.
69. Fitzpatrick F.T.A., Greenstein B.D. Effects of various steroids on regeneration of the thymus in old male rats. J. Endocrinol. 13:1987;51-55.
70. Greenstein B.D., Mander J., Fitzpatrick F.T.A. Effects of an aromatase inhibitor on testosterone-induced inhibition of thymus growth in immature female rats. J. Endocrinol. 119:1988;65-67.